Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Tax Provisions: 2022-2025

Historic Tax Provisions for Arcturus Therapeutics Holdings (ARCT) over the last 2 years, with Jun 2025 value amounting to $4,000.

  • Arcturus Therapeutics Holdings' Tax Provisions rose 102.00% to $4,000 in Q2 2025 from the same period last year, while for Jun 2025 it was -$417,000, marking a year-over-year decrease of 131.24%. This contributed to the annual value of -$4,000 for FY2024, which is 100.22% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Tax Provisions stood at $4,000 for Q2 2025, which was up 200.00% from -$4,000 recorded in Q4 2024.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Tax Provisions peaked at $900,000 during Q3 2023, and registered a low of -$217,000 during Q3 2024.
  • Its 3-year average for Tax Provisions is $202,333, with a median of $103,000 in 2023.
  • Within the past 5 years, the most significant YoY rise in Arcturus Therapeutics Holdings' Tax Provisions was 288.35% (2024), while the steepest drop was 133.33% (2024).
  • Arcturus Therapeutics Holdings' Tax Provisions (Quarterly) stood at $100,000 in 2022, then grew by 3.00% to $235,000 in 2023, then slumped by 101.70% to -$4,000 in 2024, then surged by 102.00% to $4,000 in 2025.
  • Its Tax Provisions stands at $4,000 for Q2 2025, versus -$4,000 for Q4 2024 and -$217,000 for Q3 2024.